IL2 and breast carcinoma: In this context, interesting examples of this approach are represented by the study conducted by Compte and colleagues aimed to develop an anti-CEA diabody-releasing MSCs/matrigel system39 or by Eliopoulos et al. describing the use of IL-2 producing-MSCs artificial device for breast cancer treatment42.